NCT07454304

Brief Summary

The aim of this study is to compare the analgesic efficacy of ultrasound-guided (USG) lumbar Erector Spinae Plane Block (ESPB) performed by an anesthesiologist versus a "free-hand" ESPB performed intraoperatively by the surgeon in patients undergoing Unilateral Biportal Endoscopic Discectomy (UBE). The investigators hypothesize that Us-guided would provide more effective analgesia, and USG-guided application might provide more precise local anesthetic spread.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 6, 2026

Completed
Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

3.4 years

First QC Date

March 2, 2026

Last Update Submit

March 6, 2026

Conditions

Keywords

Unilateral Biportal Endoscopic DiscectomyPostoperative analgesia managementErector Spinae Plane Block

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain Score (NRS) at 6th hour.

    Pain intensity measured by NRS (0-10, where 0=no pain, 10=worst pain).

    6 hours after surgery.

Secondary Outcomes (3)

  • Postoperative Pain Score / NRS at other intervals

    Changes from baseline pain scores at postoperative 1, 2, 12, and 24 hours

  • Rescue Analgesic Consumption

    Postoperative 24 hours period

  • Opioid-related Side Effects

    Postoperative 24 hours period

Study Arms (2)

Group US-ESPB

ACTIVE COMPARATOR

Patients in this group received an ultrasound-guided lumbar Erector Spinae Plane Block performed by an experienced anesthesiologist.

Drug: US-guided ESPB.

Group Surgeon-ESPB

EXPERIMENTAL

Patients in this group received a free-hand (intraoperative) lumbar Erector Spinae Plane Block performed by the neurosurgeon.

Drug: Surgeon-performed (Free-hand) ESPB.

Interventions

At the end of the surgery, the patient in the prone position, an experienced anesthesiologist performed the ESPB using a low-frequency convex ultrasound probe. To avoid potential interference from surgical anatomical distortion at the operative level, the block was performed one vertebral level cranial to the surgical site. Under ultrasound guidance, the transverse process was identified, and 30 ml of 0.25% bupivacaine was injected into the fascial plane between the erector spinae muscle and the transverse process

Group US-ESPB

During the UBE procedure, the surgeon performed the ESPB under direct/endoscopic vision. Similar to the USG group, the injection was performed one vertebral level above the targeted surgical level to ensure optimal fascial plane spread, unaffected by surgical tissue disruption. Before wound closure, 30 ml of 0.25% bupivacaine was injected into the space between the erector spinae muscle and the transverse process.

Group Surgeon-ESPB

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA physical status I-II.
  • Scheduled for elective UBE surgery.

You may not qualify if:

  • Infection at the injection site.
  • Coagulopathy or bleeding disorders.
  • Allergy to local anesthetics.
  • Chronic opioid use.
  • Cognitive dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University Hospital

Istanbul, Bagcilar, 34070, Turkey (Türkiye)

Location

Related Publications (2)

  • Mirkheshti A, Raji P, Komlakh K, Salimi S, Shakeri A. The efficacy of ultrasound-guided erector spinae plane block (ESPB) versus freehand ESPB in postoperative pain management after lumbar spinal fusion surgery: a randomized, non-inferiority trial. Eur Spine J. 2024 Mar;33(3):1081-1088. doi: 10.1007/s00586-023-08101-9. Epub 2024 Jan 3.

    PMID: 38170270BACKGROUND
  • Kaciroglu A, Ekinci M, Gurbuz H, Ulusoy E, Ekici MA, Dogan O, Golboyu BE, Alver S, Ciftci B. Surgical vs ultrasound-guided lumbar erector spinae plane block for pain management following lumbar spinal fusion surgery. Eur Spine J. 2024 Jul;33(7):2630-2636. doi: 10.1007/s00586-024-08347-x. Epub 2024 Jun 4.

    PMID: 38834814BACKGROUND

MeSH Terms

Conditions

Intervertebral Disc DisplacementIntervertebral disc disease

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Outcomes Assessor and participant were blinded to the study
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a prospective, randomized, single-blind, parallel-group clinical trial. Patients undergoing elective Unilateral Biportal Endoscopic Discectomy (UBE) were randomized in a 1:1 ratio into two groups using a computer-generated randomization schedule. The study model aims to compare the clinical equivalence or superiority of a surgeon-performed (free-hand) ESPB technique against the conventional ultrasound-guided (USG) ESPB performed by an anesthesiologist. Both groups received a standardized volume and concentration of local anesthetic (30 ml of 0.25% bupivacaine) to ensure comparability of the analgesic effect
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 2, 2026

First Posted

March 6, 2026

Study Start

August 1, 2022

Primary Completion

December 20, 2025

Study Completion

December 25, 2025

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared

Locations